Advance Laboratory Medicine International (ISSN 2228-8961) is a specific journal for publication of the articles in all fields of laboratory medicine (hematology, microscopy, chemistry, toxicology, parasitology, virology, bacteriology, microbiology, mycology, cytology, oncology, forensic science, genetics, bioinformatics, nanodiagnosis, information system, management, etc.). It is a peer review journal with a fast online publication after acceptance.



The journal publishes peer reviewed interesting original article, case reports, review, short communication, innovations, news and letter to editor that contribute significantly to all fields of laboratory medicine.

No article with previous publication in any form will be considered except there is a written consent from the previous publisher. Plagiarism and falsification are not accepted.

Manuscripts are reviewed by the Editorial Board and two external referees, and if your manuscript is accepted, it will be online published without any online publication charge. However, an uninvited submission is generally subjected to a possible editorial/processing charge at the rate about 100 - 250 EURO based on the length of the work (which will be notified by the director of the journal). In case that the author from a developing country has the problem on the charge, the author can directly communicate to the editor for asking for possible waiving of the mentioned charge. Authors will usually receive a decision on their manuscript within 8 weeks.




Articles should include an up-to-date review of all previous cases in the field.

Authors should seek written and signed consent to publish the information from the subjects or their care takers prior to submission. Authors will be asked to confirm informed consent was received as part of the submission process, and the manuscript must include a statement to this effect by including declaration of conflict of interest section.



            Submission should be directly to the Director of the journal

Professor Hai Err


Upon submitting an article, authors should be agreed to abide by an open access Creative Commons license (CC-BY).

After submission, the author will be notified for the primary check-in and suggested for further submission via the online submission tool of the journal.  The author will be noted for the English editing requirement before submission at this stage.

An article will only be accepted for peer review in the following format:

  • Title page
  • Abstract
  • Introduction
  • Presentation
  • Discussion
  • Conclusions
  • Patient’s perspective (optional)
  • List of abbreviations used (if any)
  • Consent
  • Competing interests
  • Authors' contributions
  • Acknowledgements and Funding
  • References
  • Illustrations and figures
  • Figure legends (if any)
  • Additional data files (if any)


Title page 

The first page of the manuscript should be a dedicated title page, including the title of the article.

The full names, telephone, institutional addresses and email addresses for all authors must be included on the title page. The corresponding author should also be indicated.

Supporting fund as well as declaration of previous presentation/publication of the work has to clarified in this page.


This should start on page 2 of the manuscript. The abstract must not exceed 350 words. No structured abstract is suggested. Also, please do not use abbreviations or references in the abstract.  

List of abbreviations

If abbreviations are used in the text, either they should be defined in the text where first used, or a list of abbreviations can be provided, which should precede the consent section.


Manuscripts will not be peer-reviewed if a statement of patient consent is not present.

Competing interests

Authors are required to complete a declaration of competing interests. All competing interests that are declared will be listed at the end of published articles. Where an author gives no competing interests, the listing will read “no competing interests” is declared.

Authors' contributions

In order to give appropriate credit to each author of a paper, the individual contributions of authors to the manuscript should be specified in this section (in clear percentage).

Acknowledgements and Funding

Please acknowledge anyone who contributed towards the study by making substantial contributions to conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for important intellectual content, but who does not meet the criteria for authorship.


Publication ethics

Please follow the standard international guidelines on publication ethics (Please see the guidelines of the Committee on Publication Ethics (COPE), the World Association of Medical Editors (WAME), the International Committee of Medical Journal Editors (ICMJE), and Consolidated Standards Of Reporting Trials (Consort)). Any violations of the standards are not acceptable and will be strictly managed according to the guidelines. As a brife guideline, please carefully read and follow these principles


A: Conflict of interest

          Public trust in the peer review process and the credibility of published articles depend in part on how well conflict of interest is handled during writing, peer review, and editorial decision making. Conflict of interest exists when an author (or the author's institution), reviewer, or editor has financial or personal relationships that inappropriately influence (bias) his or her actions (such relationships are also known as dual commitments, competing interests, or competing loyalties). These relationships vary from those with negligible potential to those with great potential to influence judgment, and not all relationships represent true conflict of interest. The potential for conflict of interest can exist whether or not an individual believes that the relationship affects his or her scientific judgment. Financial relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony) are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, and of science itself. However, conflicts can occur for other reasons, such as personal relationships, academic competition, and intellectual passion. If these conflicts occur, they have to reported as well.

B: Informed consent

      As a principle, ratients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, will not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should also identify Individuals who provide writing assistance and disclose the funding source for this assistance. Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.

C: Human and Animal Rights

       When reporting experiments on human subjects, author(s) has (have) to indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should indicate whether the institutional and national guide for the care and use of laboratory animals was followed. Lack of these evidences, the work will be rejected.

D: Plagiarism, duplication and misconduct

       The journal has policies against any kinds of plagiarism, duplication and misconduct. Each submitted will be screened for plagiarism by plagiarism detection software and it will be rejected with notification to the author(s)' institute in case of any plagiarism detected. Also, if the plagiarism, duplication or misconduct is seen after publication, retraction will be done and notification to the author(s)' institute will also be subsequently done.


Authors must search for and cite published work (only in periodic journal, not a book or internet source) in their submitted papers. There should be no more than 50 references. All references must be numbered consecutively, in square brackets (not superscript), in the order in which they are cited in the text, followed by any in tables or legends. Reference citations should not appear in titles or headings. Each reference must have an individual reference number.

Only articles and abstracts that have been published or are in press, or are available through public e-print/preprint servers, may be cited; unpublished abstracts, unpublished data and personal communications should not be included in the reference list. The example of reference is hereby shown:

Article within a journal
1. Mahony JB. Nucleic acid amplification-based diagnosis of respiratory virus infections. Expert Rev Anti Infect Ther. 2010; 8: 1273-92.


Article in press with DOI
2. Chen HX, Chen BG, Shi WW, Zhen R, Xu DP, Lin A, Yan WH. Induction of cell surface HLA-G expression in pandemic H1N1 2009 and seasonal H1N1 influenza virus infected patients. Hum Immunol. 2010 Nov 15. [Epub ahead of print]


 The journal welcomes and seeks for experts in any field to join the editorial as well as the reviewer board of the journal. Please indicate your interest directly to the managing director of the journal.


Query on the submission, publication, charge, and sponsor should be direct to the managing director of the journal.


Archiving and copyright policies


Copyright of all printed materials is held by the WF publisher.  However, the authors are allowable to retain copyrights and publishing rights of the online publication version. The director editors, editorial board, sponsoring organizations, publisher and E- publisher do not accept responsibility for the statements expressed by authors in their contributions. The journal allows free access (Open Access) to its published articles and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional/subject-based repository.

The entire contents of the journals published by the journal are protected under Indian and international copyrights. The publisher, however, grants to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, perform and display the work publicly and to make and distribute derivative works in any digital medium for any reasonable non-commercial purpose, subject to proper attribution of authorship and ownership of the rights. The publisher also grants the right to make small numbers of printed copies for their personal non-commercial use under Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported (CC BY-NC-SA 3.0) License.


Privacy Policy

Advance Laboratory Medicine International is committed to maintaining your confidence and trust with respect to the privacy of the personally identifiable information we collect from you. This privacy policy sets forth our practices regarding collection, use and disclosure of information collected through or in connection with the journal.

We may request users of this site to provide personal information. The information collected directly from a user may include contact information such as the user's name, phone number, e-mail address, and postal address. In general, you can visit our journal without divulging any personal information. In order to access certain content and to make use of the full functionality and advanced personalization features of the site we may ask you to register by completing and submitting a registration form, which may request additional information, such as work setting or principal professional field.

We use non-identifying information collected on our Web Site in the aggregate to better understand your use of the Web Site. These data enable us to become more familiar with whom customers visit our site, how often they visit, and what parts of the site they visit most often. This information is collected automatically and requires no action on your part.

We may contract with third-party advertisers or service providers that post on the site banner advertisements, which may link to other websites not under our control. Or that use technologies to collect and use user data to measure the effectiveness of their ads or deliver relevant marketing messages and advertisements. Use of these technologies by these third parties is subject to their own privacy policies, which may differ from this privacy policy. We are not responsible or liable for any content, advertising, products or other materials offered from such third parties.

We will not disclose any personal information without your consent except under the following circumstances:

1. In response to court orders, or legal process, or to establish or exercise our rights to defend against legal claims;

2. If we believe it is necessary to investigate, prevent, or take action regarding illegal activities, suspected fraud, safety of person or property, violation of our policies, or as otherwise required by law


Copyright and Disclaimer

Copyright of all material is held by the WF publisher. The director editors, editorial board, sponsoring organizations, publisher and E- publisher do not accept responsibility for the statements expressed by authors in their contributions.

The entire contents of the Case Study and Case Report are protected under copyrights. The Journal, however, grants to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, perform and display the work publicly and to make and distribute derivative works in any digital medium for any reasonable non-commercial purpose, subject to proper attribution of authorship and ownership of the rights. You may not otherwise use, modify, publish, transmit, transfer or sell, rent, lease, reproduce, create derivative works from, distribute, circulate, disseminate, perform, link, display, or in any way exploit any product or Intellectual Property, in whole or in part, except as expressly permitted in any agreement you may have with Case Study and Case Report or with the prior written consent of the appropriate owner.

You may not use the site to publish or distribute any information which is illegal, which violates or infringes upon the rights of any other person, which is defamatory, abusive, hateful, threatening or vulgar, or which is otherwise actionable at law.

You may not, without the approval of the journal, use the site to publish or distribute any advertising, promotional material, or solicitation to other users of the site to use any goods or services. For example (but without limitation), you may not use the site to conduct any business, to solicit the performance of any activity that is prohibited by law, or to solicit other users to become subscribers of other information services. Similarly, you may not use the site to download and redistribute public information or shareware for personal gain or distribute multiple copies of public domain information.

All material published in the Case Study and Case Report undergoes peer review to ensure fair balance, objectivity, independence, and relevance to educational need. The editors of the material have consulted sources believed to be reliable in their efforts to provide information that is in accord with the standards accepted at the time of posting. However, in view of the possibility of error by the authors, editors, or publishers of the works contained in the journal, nor its publishers, nor any other party involved in the preparation of material contained in the Case Study and Case Report represents or warrants that the information contained herein is in every respect accurate or complete, and they are not responsible for any errors or omissions or for the results obtained from the use of such material. Readers are encouraged to confirm the information contained herein with other sources.



Pattanamon Ujjin

Associate Professor, Head of Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok Thailand 10330

Abdul M. Awan

Senior Scientific Officer, Institute of Biomedical & Genetic Engineering, Pakistan

Nabil Mohie Abdel-Hamid

Professor, Cancer Biologist and Chairman of Biochemistry Dept. Director of Hepatocellular Carcinoma Research Unit. Pharmacy College , Minia Univ, Egypt

Abid Azhar

Professor & Co-Director General The Karachi Institute of Biotechnology & Genetic Engineering (KIBGE) Islamabad Pakistan

Emmanuel Ike Ugwuja

Department of Chemical Pathology, Faculty of Clinical Medicine, Ebonyi State University, P.M.B. 053 Abakaliki, Nigeria

Fatima Shad K

Human Physiology PAP RSB Institute of Health Sciences Universiti Brunei Darussalam Jalan Tungku Link, Gadong BE 1410 Brunei Darussalam

Gerald Wollard NZ

Chair for the Australasian Association of Clinical Biochemists, Acukland, Zew Zealand

Yasemin Benderli

Cihan Kayseri Education and Research Hospital, Turkey




GENAMICS JournalSeek